Reports & Presentations
Subsidiary Financials 2023 -24
- Glenmark Ukrain LLC
- Viso Farmaceautica SLU
- Sintesy Pharma S.R.L.
- Glenmark Uruguay SA
- Glenmark South Africa Proprietary Limited
- Glenmark Philippines Inc.
- Glenmark Phartmaceuticals Colombia SAS
- Glenmark Pharmaceuticals Venezuela, C.A.
- Glenmark Pharmaceuticals SP. Z O.O.
- Glenmark Pharmaceuticals South Africa Proprietary Limited.
- Glenmark Pharmaceuticals SK sro
- Glenmark Pharmaceuticals singapore PTE. LTD.
- Glenmark Pharmaceuticals s.r.o.
- Glenmark Pharmaceuticals Peru S.A.C.
- Glenmark Pharmaceuticals Nordic AB
- Glenmark Pharmaceuticals Nigeria Ltd.
- Glenmark Pharmaceuticals Mexico, SA DEC. V.
- Glenmark Pharmaceuticals Malaysia SDN
- Glenmark Pharmaceuticals Kenya Limited
- Glenmark Pharmaceuticals FZE
- Glenmark Pharmaceuticals Egypt SAE.
- Glenmark Pharmaceuticals Ecuador SA
- Glenmark Pharmaceuticals Distribution s.r.o.
- Glenmark Pharmaceuticals BV
- Glenmark Pharmaceuticals (Thailand) Co. Ltd.
- Glenmark Pharmaceuticals (Australia) Pty Limited.
- Glenmark Pharmaceutical Spa.
- Glenmark Dominicana SRL.
- Glenmark Arzneimittel Gmbh.
- Glenmark Pharmaceuticals Europe Limited.
- Glenmark Generics S.A.
- Glenmark Farmaceutica Ltda
- Glenmark Arzenimittel GmbH - Austria.
- GPCI signed financials FY24
- Glenmark Therapeutics Inc.
- Glenmark Specialty SA
